SFA Therapeutics
Edit

SFA Therapeutics

http://sfatherapeutics.com/
Last activity: 12.01.2023
Active
Categories: BioTechBodyCauseDevelopmentDrugHumanInformationPlatformResearchTechnology
SFA Therapeutics is a clinical stage start-up biotech company developing compounds discovered in human microbiome. This patented and proprietary platform is based on immuno-modulation of inflammatory factors derived from human gut microbiome. The technology is licensed from and supported by research at Temple University in Philadelphia. These products are a unique native immunotherapy platform with activity currently being investigated in cancer, liver, and auto-immune disease.
Mentions
27
Location: United States, Pennsylvania, Philadelphia
Employees: 1-10
Total raised: $4M

Investors 8

Funding Rounds 1

DateSeriesAmountInvestors
20.06.2022-$4M-

Mentions in press and media 27

DateTitleDescription
12.01.2023‘A Little Company With A Big Vision’: Temple Spinout Advancing New Way To Treat Autoimmune DisordersA Temple University spinout working on a new way to treat autoimmune disorders has been approved to begin human testing of a potential treatment for an inflammatory liver disease. SFA Therapeutics of Jenkintown received Food and Drug Admini...
17.10.2022Dr. Daniel Sauder joins the SFA Therapeutics Scientific Advisory BoardDaniel Sauder, MD An experienced Key Opinion Leader in Dermatology, Dr. Sauder will add significant input to the dermatology development program at SFA Therapeutics I am most enthusiastic about working with the talented team at SFA. Their m...
20.06.2022SFA THERAPEUTICS, INC. CLOSES SEED ROUND RAISE of $4MTreating the root cause of autoimmune disease™ Funds are focused on Phase 1b clinical trial in psoriasis SFA Therapeutics wishes to thank our lead investors for the confidence that they have shown in our new approach to the treatment of aut...
24.01.2022Ben Franklin Approved $2.4M in 12 Early Stage Companies
06.01.2022Pismo Ventures' National Venture Plan Startup Competition Announces WinnersNational Startup Competition by Pismo Ventures - Winners Announced “For the second year in a row, we were able to provide a truly unique experience for startup businesses within different industries while providing them access and exposure ...
01.09.2021Here are all the companies from Day 2 of Y Combinator’s Summer 2021 Demo DayWelcome back to TechCrunch’s continuing coverage of Y Combinator’s Summer 2021 Demo Day! This is Day Two. If you haven’t caught up yet on what happened during the first day, you can read our recap of all the presenting companies here, our f...
24.08.2021Y Combinator startup Lumify Care, cofounded by a Penn grad, is the accelerator’s first nurse-led teamLike many 2021 graduates, University of Pennsylvania alum Anthony Scarpone-Lambert knew he’d be entering a pandemic-tinged workforce. For former nursing students like him, their real-world experience has been wholly consumed by the coronavi...
13.07.2021These Philly Startups Were Accepted into Y Combinator’s Summer 2021 CohortTherapeutics company SFA Therapeutics, Inc. and AI-based customer-facing calls startup q&ai joined the summer 2021 batch. This summer session includes 152 companies from five continents, and startups offering services in industries such...
12.07.2021These Philly startups were accepted into Y Combinator’s summer 2021 cohortTwo Philadelphia-based startups are participating in the prominent Silicon Valley accelerator Y Combinator this summer for its second summer of virtual sessions running from June through August. Therapeutics company SFA Therapeutics, Inc. a...
13.05.2021To expand or not to expand? Houston researcher weighs in on global growthYou built your business from the ground up, patiently finding techniques and products that work, carefully crafting solid bonds with your clients. Then one day a new project, opportunity or simple request poses a question: Is it time to bra...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In